Product Assessment

Objective :

Analysis of Cyclophosphamide products in development in Oncology space along with periodic Assessment of development of API competitors to provide understating of API product landscape relating to cyclophosphamide development and launch.

Problem Statement:

A large pharma client was working to develop their cyclophosphamide API and FD and was interested to assess competitive products in the same domain and area to provide benchmarking of their asset in comparison to their competitors The client requested periodic reports (Quarterly) on the developmental milestones of competitor companies, thorough assessment of the competitor products through Secondary and Primary CI inputs.

Our Methodology:

• Conference Assessment
• Company Assessment
• R&D development Assessment
• FD Formulation Assessment
• Primary Assessment
• Analysis
• Periodic Insight Generation

Results:

DelveInsight provided effective quarterly reports to track developmental, regulatory & commercial milestones of competitor products.

XX Company (Summary Findings)

• XX has the API for this product
• XX doesn’t have the FD
• XX is in direct business with most of the European and US customers and also through distributors/agents for API

YY Company (Summary Findings)

• The product is available in the market.
• Providing bulk capacity will not be possible
• Capacity constraint problems have arisen, creating production backlogs in Eastern Europe and Latin American market.